These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2066638)

  • 41. The effect of calcium blockade with verapamil on experimental cyclosporine nephrotoxicity.
    Orugun EO; Smart LM; Whiting PH
    Transplant Proc; 1991 Feb; 23(1 Pt 1):354-5. PubMed ID: 1990550
    [No Abstract]   [Full Text] [Related]  

  • 42. Nephrotoxicity of cyclosporine in humans: effect of cyclosporine on glomerular filtration and proximal tubular reabsorption.
    Heering P; Schadewaldt P; Bach D; Grabensee B
    Clin Investig; 1993 Dec; 71(12):1010-5. PubMed ID: 8124053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nephrotoxicity of cyclosporine A and cyclosporine G in a rat model.
    Tejani A; Lancman I; Pomrantz A; Khawar M; Chen C
    Transplantation; 1988 Jan; 45(1):184-7. PubMed ID: 3336915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal injury induced by long-term administration of cyclosporin A to rats.
    Bertani T; Perico N; Abbate M; Battaglia C; Remuzzi G
    Am J Pathol; 1987 Jun; 127(3):569-79. PubMed ID: 3591904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new proposal for the mechanism of cyclosporine A nephrotoxicity. Inhibition of renal microsomal protein chain elongation following in vivo cyclosporine A.
    Buss WC; Stepanek J; Bennett WM
    Biochem Pharmacol; 1989 Nov; 38(22):4085-93. PubMed ID: 2597185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of nifedipine on cyclosporine A-induced nephrotoxicity, urinary endothelin excretion and renal endothelin receptor number.
    Brooks DP; Ohlstein EH; Contino LC; Storer B; Pullen M; Caltabiano M; Nambi P
    Eur J Pharmacol; 1991 Feb; 194(1):115-7. PubMed ID: 1647960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic cyclosporine nephrotoxicity. A rodent model.
    Gillum DM; Truong L; Tasby J; Migliore P; Suki WN
    Transplantation; 1988 Aug; 46(2):285-92. PubMed ID: 3406978
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renal blood flow, glomerular filtration rate, and renal morphology in cyclosporine-induced acute renal failure in Munich-Wistar rats.
    Racusen LC; Kone BC; Whelton A; Solez K
    Am J Kidney Dis; 1986 Nov; 8(5):319-22. PubMed ID: 3788971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal cortical mitochondrial integrity in experimental cyclosporine nephrotoxicity.
    Elzinga LW; Mela-Riker LM; Widener LL; Bennett WM
    Transplantation; 1989 Jul; 48(1):102-6. PubMed ID: 2749885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Experimental model of lead nephropathy. I. Continuous high-dose lead administration.
    Khalil-Manesh F; Gonick HC; Cohen AH; Alinovi R; Bergamaschi E; Mutti A; Rosen VJ
    Kidney Int; 1992 May; 41(5):1192-203. PubMed ID: 1614034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of nifedipine on renal haemodynamics in an animal model of cyclosporin A nephrotoxicity.
    McNally PG; Baker F; Mistry N; Walls J; Feehally J
    Clin Sci (Lond); 1990 Sep; 79(3):259-66. PubMed ID: 2169375
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early renal pathophysiology in an acute model of cyclosporine nephrotoxicity in rats.
    Racusen LC; Kone BC; Solez K
    Ren Fail; 1987; 10(1):29-37. PubMed ID: 3823505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclosporine nephrotoxicity.
    Ryffel B; Mihatsch MJ
    Toxicol Pathol; 1986; 14(1):73-82. PubMed ID: 3520782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of cyclosporine-induced nephrotoxicity with dietary glycine.
    Thurman RG; Zhong Z; von Frankenberg M; Stachlewitz RF; Bunzendahl H
    Transplantation; 1997 Jun; 63(11):1661-7. PubMed ID: 9197363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclosporine and experimental renal ischemic injury.
    Chow SS; Thorner P; Baumal R; Wilson DR
    Transplantation; 1986 Feb; 41(2):152-6. PubMed ID: 3946012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclosporine nephrotoxicity in rats with an acute reduction of renal function.
    Provoost AP
    Am J Kidney Dis; 1986 Nov; 8(5):314-8. PubMed ID: 3788970
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experimental model of lead nephropathy. III. Continuous low-level lead administration.
    Khalil-Manesh F; Gonick HC; Cohen AH
    Arch Environ Health; 1993; 48(4):271-8. PubMed ID: 8357279
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term analysis of glomerular filtration rate and hypertension in adult liver transplant recipients treated with cyclosporine A.
    Hauters P; de Hemptinne B; Carlier M; Malaise J; Ottobrelli A; Delaby J; Balducci G; Kestens PJ; Otte JB
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1458-9. PubMed ID: 1989264
    [No Abstract]   [Full Text] [Related]  

  • 59. The effect of salt intake on cyclosporine-induced impairment of renal function in rats.
    Gerkens JF; Bhagwandeen SB; Dosen PJ; Smith AJ
    Transplantation; 1984 Oct; 38(4):412-7. PubMed ID: 6388064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclosporine nephrotoxicity: blood volume, sodium conservation, and renal hemodynamics.
    Devarajan P; Kaskel FJ; Arbeit LA; Moore LC
    Am J Physiol; 1989 Jan; 256(1 Pt 2):F71-8. PubMed ID: 2912168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.